Trademark: 87232901
Word
DARTEMZI
Status
Dead
Status Code
710
Status Date
Friday, February 16, 2024
Serial Number
87232901
Registration Number
5254825
Registration Date
Tuesday, August 1, 2017
Mark Type
4000
Filing Date
Thursday, November 10, 2016
Published for Opposition
Tuesday, May 16, 2017
Cancellation Date
Friday, February 16, 2024

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Feb 16, 2024
Cancelled Sec. 8 (6-Yr)
Aug 1, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 1, 2017
Registered-Principal Register
May 16, 2017
Official Gazette Publication Confirmation E-Mailed
May 16, 2017
Published For Opposition
Apr 26, 2017
Notification Of Notice Of Publication E-Mailed
Apr 7, 2017
Law Office Publication Review Completed
Apr 3, 2017
Approved For Pub - Principal Register
Mar 29, 2017
Teas/Email Correspondence Entered
Mar 29, 2017
Correspondence Received In Law Office
Mar 22, 2017
Assigned To Lie
Mar 6, 2017
Teas Response To Suspension Inquiry Received
Feb 17, 2017
Notification Of Letter Of Suspension E-Mailed
Feb 17, 2017
Letter Of Suspension E-Mailed
Feb 17, 2017
Suspension Letter Written
Feb 16, 2017
Assigned To Examiner
Nov 16, 2016
New Application Office Supplied Data Entered
Nov 14, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24